This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This VGLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the Central region of human VGLL4.
VGLL4
Reactivité: Humain, Souris, Rat
WB, IF (p)
Hôte: Lapin
Polyclonal
AbBy Fluor® 350
Indications d'application
WB: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Date de péremption
6 months
Trynka, Zhernakova, Romanos, Franke, Hunt, Turner, Bruinenberg, Heap, Platteel, Ryan, de Kovel, Holmes, Howdle, Walters, Sanders, Mulder, Mearin, Verbeek, Trimble, Stevens, Kelleher, Barisani et al.: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." dans: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).
Chen, Mullett, Stewart: "Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes." dans: The Journal of biological chemistry, Vol. 279, Issue 29, pp. 30800-6, (2004) (PubMed).
anticorps DKFZp459C0333, anticorps VGL-4, anticorps BC048841, anticorps vestigial-like family member 4, anticorps vestigial like family member 4, anticorps Vgll4, anticorps VGLL4
Sujet
VGLL4 may act as a specific coactivator for the mammalian TEFs (By similarity).